Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 3
Submit an article Journal homepage
240
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03)

José Francisco TomásM. D. Anderson International España, Madrid, SpainCorrespondence[email protected]
,
Carlos MontalbánHospital Universitario Ramón y Cajal, Madrid, Spain
,
Alberto Fernández De SevillaICO, Barcelona, Spain
,
JoaquÍn MartÍnez-lópezHospital Doce de Octubre, Madrid, Spain
,
Nicolás DÍazHospital Xeral-Calde, Lugo, Spain
,
Miguel CanalesHospital La Paz, Madrid, Spain
,
Rafael MartÍnezHospital Clínico San Carlos, Madrid, Spain
,
Pedro Sánchez-GodoyHospital Severo Ochoa-Leganes, Madrid, Spain
,
MarÍa Dolores CaballeroHospital Universitario de Salamanca, Salamanca, Spain
,
Javier PeñalverFundación Hospital Alcorcón, Alcorcón, Spain
,
Elena PrietoFundación Jiménez Díaz, Madrid, Spain
,
Antonio SalarHospital del Mar, Barcelona, Spain
,
Carmen BurgaletaHospital Principe de Asturias, Alcalá de Henares, Spain
,
José Antonio QueizánHospital General de Segovia, Segovia, Spain
,
Roberto BajoHospital Infanta Cristina, Badajoz, Spain
,
Raquel De oñaM. D. Anderson International España, Madrid, Spain
&
Javier De La SernaHospital Doce de Octubre, Madrid, Spain
 show all
Pages 409-416 | Received 08 Oct 2010, Accepted 23 Nov 2010, Published online: 28 Jan 2011

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Sean Harrop, Aaron Polliack & Constantine S. Tam. (2021) Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyond. Leukemia & Lymphoma 62:4, pages 771-778.
Read now
Alessandro Gozzetti, Alberto Fabbri, Emanuele Cencini & Monica Bocchia. (2015) Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders. Leukemia & Lymphoma 56:6, pages 1916-1917.
Read now
Chadi Nabhan, Nicholas J. Ollberding, Dana Villines, Brian C.-H. Chiu, Donne Bennett D. Caces, Tina V. Valdez, Michele Ghielmini, Shu-Fang Hsu Schmitz & Sonali M. Smith. (2014) A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Leukemia & Lymphoma 55:6, pages 1288-1294.
Read now
Constantine S. Tam & John F. Seymour. (2011) Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost?. Leukemia & Lymphoma 52:5, pages 729-731.
Read now
John W. Sweetenham & Arnold S. Freedman. (2011) Early initial therapy of advanced follicular lymphoma: the need for vigilance. Leukemia & Lymphoma 52:3, pages 355-357.
Read now

Articles from other publishers (4)

E S Nesterova, S K Kravchenko, Ya K Mangasarova, L V Plastinina, V N Dvirnyk, A M Kovrigina, I A Shchupletsova, T N Obukhova, E G Gemdzhian, I A Vorobyev & A I Vorobyev. (2017) Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease. Terapevticheskii arkhiv 89:7, pages 45-50.
Crossref
Loretta J. Nastoupil, Peter McLaughlin, Lei Feng, Sattva S. Neelapu, Felipe Samaniego, Fredrick B. Hagemeister, Ana Ayala, Jorge E. Romaguera, Andre H. Goy, Eleanor Neal, Michael Wang, Luis Fayad, Michelle A. Fanale, Yasuhiro Oki, Jason R. Westin, Maria A. Rodriguez, Fernando Cabanillas & Nathan H. Fowler. (2017) High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study. British Journal of Haematology 177:2, pages 263-270.
Crossref
Emanuele Cencini, Alberto Fabbri, Luana Schiattone, Giulia Bartalucci & Monica Bocchia. (2014) Low‐dose chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab in follicular lymphoma. European Journal of Haematology 94:3, pages 277-278.
Crossref
Fátima De la Cruz Vicente, Estrella Carrillo-Cruz, Maria Sole Rodriguez, Ana Marín Niebla, Maria Luz Martino Galiana, Jose Falantes Gonzalez, Isabel Montero Cuadrado, Jose Gonzalez Campos, Ildefonso Espigado Tocino, Eduardo Rios-Herranz & Jose Antonio Perez-Simón. (2014) Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma. European Journal of Haematology 93:6, pages 469-475.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.